Apellis Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell APLS and other ETFs, options, and stocks.

About APLS

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which develops novel therapeutic and complement immunotherapies for the treatment of complement-dependent autoimmune and inflammatory diseases through APL-2 product. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA. 

CEO
Cedric Francois
CEOCedric Francois
Employees
476
Employees476
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2009
Founded2009
Employees
476
Employees476

APLS Key Statistics

Market cap
6.70B
Market cap6.70B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.64M
Average volume1.64M
High today
$68.00
High today$68.00
Low today
$58.46
Low today$58.46
Open price
$68.00
Open price$68.00
Volume
4.86M
Volume4.86M
52 Week high
$70.00
52 Week high$70.00
52 Week low
$30.17
52 Week low$30.17

Analyst ratings

83%

of 18 ratings
Buy
83.3%
Hold
11.1%
Sell
5.6%

APLS Earnings

-$2.72
-$1.81
-$0.91
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 7, After Hours
ActualExpected Nov 7, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.